Table 3.
Category | Component | Description | Identification method |
---|---|---|---|
Drugs that interact with sulfonylureas | ACE inhibitorsa | benazepril, enalapril, lisinopril, perindopril, ramipril, captopril, fosinopril, moexipril, quinapril, trandolapril | NDC, dispensing date, days' supply |
ARBsa | losartan, candesartan, valsartan, irbesartan, eprosartan, olmesartan, telmisartan, azilsartan | NDC, dispensing date, days' supply | |
Beta blockersa | acebutolol, atenolol, betaxolol, bisoprolol, carteolol, carvedilol, labetalol, metoprolol, nadolol, nebivolol, penbutolol, pindolol, propranolol, sotalol, timolol | NDC, dispensing date, days' supply | |
MAO inhibitorsa | isocarboxazid, phenelzine, selegiline, tranylcypromine | NDC, dispensing date, days' supply | |
Quinolonesb | cinoxacin, ciprofloxacin, enoxacin, gatifloxacin, gemifloxacin, grepafloxacin, levofloxacin, lomefloxacin, moxifloxacin, nalidixic acid, norfloxacin, ofloxacin, sparfloxacin, trovafloxacin | NDC, dispensing date, days' supply | |
Salicylatesa | aspirin, choline salicylate, magnesium salicylate, magnesium salicylate tetrahydrate, salsalate, sodium salicylate | NDC, dispensing date, days' supply | |
Othersa | sulfamethoxazole, trimethoprim, haloperidol, quinidine, quinine, pentamidine, chloramphenicol, chloroquine, clofibrate, disopyramide | NDC, dispensing date, days' supply | |
Drugs that can cause hyperglycemia | Atypical antipsychoticsa | aripiprazole, clozapine, iloperidone, lurasidone, olanzapine, paliperidone, quetiapine, risperidone, ziprasidone | NDC, dispensing date, days' supply |
Calcineurin inhibitorsa | cyclosporine, sirolimus, tacrolimus | NDC, dispensing date, days' supply | |
Corticosteroidsa | betamethasone, budesonide, cortisone, dexamethasone, fluodrocortisone, hydrocortisone, methylprednisolone, prednisolone, prednisone, triamcinolone | NDC, dispensing date, days' supply | |
Protease inhibitorsa | amprenavir, atazanavir, darunavir, fosamprenavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir, tipranavir | NDC, dispensing date, days' supply | |
Retinoida | tretinoin, isotretinoin, acitretin | NDC, dispensing date, days' supply | |
Thiazide and thiazide-like diureticsa | bendroflumethiazide, benthiazide, chlorothiazide, chlorthalidone, hydrochlorothiazide, hydroflumethiazide, indapamide, methyclothiazide, metolazone, polythiazide, trichlormethiazide | NDC, dispensing date, days' supply | |
Drugs that interact with sulfonylureas | CYP2C9 inhibitors | fluconazoleb, cotrimoxazoleb, fenofibratea | NDC, dispensing date, days' supply |
CYP3A4 inhibitors | azithromycinb, clarithromycinb, erythromycinb, simvastatina, gemfibrozila | NDC, dispensing date, days' supply | |
Major non-chronic condition that may affect hypoglycemia | Acute infectionb | acute infection identified at any position of discharge diagnosis on inpatient or outpatient claims | ICD-9-CM diagnosis codes, admission or service date |
Average daily dose of object drugs* | Average daily dose of sulfonylureas and metforminc | defined by [(prescription quantity × strength) / (prescription days’ supply)] | NDC, dispensing date, days' supply, quantity, strength |
NDC: National Drug Code. CYP: cytochrome P450 enzyme. ICD-9-CM: International Classification of Diseases 9th Revision Clinical Modification. CPT: Current Procedural Terminology. HCPCS: Healthcare Common Procedure Coding System. ACE: angiotensin-converting enzyme. ARB: angiotensin II receptor antagonists. MAO: monoamine oxidase.
Measured as a day-level binary variable indicating being dispensed on the current day (refers to each day during the observation time as current) or any time during the 31 days prior to the current day.
Measured as a day-level binary variable indicating being dispensed on the current day or any time during the 15 days prior to the current day.
Measured as a day-level continuous variable on the current day, based on the prescription active on the current day.
covariates additionally adjusted in the sensitivity analysis.